scispace - formally typeset
Open AccessJournal ArticleDOI

Roles of Acyl-CoA:Diacylglycerol Acyltransferases 1 and 2 in Triacylglycerol Synthesis and Secretion in Primary Hepatocytes

Reads0
Chats0
TLDR
The data suggest that DGAT1 and DGAT2 can compensate for each other to synthesize triacylglycerol, butTriacyl glycerol synthesized by DGAT 1 is preferentially channeled to oxidation, whereas DGAT 2 synthesizes triacy lglycersol destined for very low–density lipoprotein assembly.
Abstract
Objective— Very low–density lipoprotein assembly and secretion are regulated by the availability of triacylglycerol. Although compelling evidence indicates that the majority of triacylglycerol in very low–density lipoprotein is derived from re-esterification of lipolytic products released by endoplasmic reticulum–associated lipases, little is known about roles of acyl-CoA:diacylglycerol acyltransferases (DGATs) in this process. We aimed to investigate the contribution of DGAT1 and DGAT2 in lipid metabolism and lipoprotein secretion in primary mouse and human hepatocytes. Approach and Results— We used highly selective small-molecule inhibitors of DGAT1 and DGAT2, and we tracked storage and secretion of lipids synthesized de novo from [ 3 H]acetic acid and from exogenously supplied [ 3 H]oleic acid. Inactivation of individual DGAT activity did not affect incorporation of either radiolabeled precursor into intracellular triacylglycerol, whereas combined inactivation of both DGATs severely attenuated triacylglycerol synthesis. However, inhibition of DGAT2 augmented fatty acid oxidation, whereas inhibition of DGAT1 increased triacylglycerol secretion, suggesting preferential channeling of separate DGAT-derived triacylglycerol pools to distinct metabolic pathways. Inactivation of DGAT2 impaired cytosolic lipid droplet expansion, whereas DGAT1 inactivation promoted large lipid droplet formation. Moreover, inactivation of DGAT2 attenuated expression of lipogenic genes. Finally, triacylglycerol secretion was significantly reduced on DGAT2 inhibition without altering extracellular apolipoprotein B levels. Conclusions— Our data suggest that DGAT1 and DGAT2 can compensate for each other to synthesize triacylglycerol, but triacylglycerol synthesized by DGAT1 is preferentially channeled to oxidation, whereas DGAT2 synthesizes triacylglycerol destined for very low–density lipoprotein assembly.

read more

Citations
More filters
Journal ArticleDOI

Lipid Droplet Biogenesis.

TL;DR: A model of LD formation from the ER in distinct steps is presented and the biology of proteins that govern this biophysical process are highlighted, as are connections with physiology and diseases linked to alterations in LD biology.
Journal ArticleDOI

Non-alcoholic steatohepatitis: emerging molecular targets and therapeutic strategies

TL;DR: Research into novel therapeutic approaches for non-alcoholic fatty liver disease include the modulation of nuclear transcription factors; agents that target lipotoxicity and oxidative stress; and the modulationof cellular energy homeostasis, metabolism and the inflammatory response.
Journal ArticleDOI

Bioactive Lipid Species and Metabolic Pathways in Progression and Resolution of Nonalcoholic Steatohepatitis.

TL;DR: The concept that NASH is a disease that can resolve and the roles of lipid molecules in the resolution of inflammation and regression of fibrosis are discussed.
Journal ArticleDOI

The regulation of hepatic fatty acid synthesis and partitioning: the effect of nutritional state

TL;DR: How diet and metabolic diseases affect hepatic fatty acid partitioning is outlined, which indicates how the interaction between these pathways requires optimization of physiologically relevant models of hepatic fat and carbohydrate metabolism.
Journal ArticleDOI

Role of DGAT enzymes in triacylglycerol metabolism.

TL;DR: Differences are distinguished between the two DGAT enzymes by comparing the genes that encode them, their proposed topologies, the proteins they interact with, and their roles in lipid metabolism.
References
More filters
Journal ArticleDOI

Molecular mediators of hepatic steatosis and liver injury

TL;DR: Recent advances in the understanding of the molecular events contributing to hepatic steatosis and nonalcoholic steatohepatitis are highlighted.
Journal ArticleDOI

Triglyceride accumulation protects against fatty acid-induced lipotoxicity

TL;DR: This work demonstrates in cultured cells that the relative toxicity of two common dietary long chain fatty acids is related to channeling of these lipids to distinct cellular metabolic fates, and supports a model of cellular lipid metabolism in which unsaturated fatty acids serve a protective function against lipotoxicity though promotion of triglyceride accumulation.
Journal ArticleDOI

Obesity and Nonalcoholic Fatty Liver Disease: Biochemical, Metabolic and Clinical Implications

TL;DR: It is not clear whether NAFLD causes metabolic dysfunction or whether metabolic dysfunction is responsible for IHTG accumulation, or possibly both, but it is likely that abnormalities in fatty acid metabolism are key factors involved in the development of insulin resistance, dyslipidemia, and other cardiometabolic risk factors associated withNAFLD.
Journal ArticleDOI

High glucose level and free fatty acid stimulate reactive oxygen species production through protein kinase C--dependent activation of NAD(P)H oxidase in cultured vascular cells.

TL;DR: Both high glucose level and palmitate may stimulate ROS production through PKC-dependent activation of NAD(P)H oxidase in both vascular SMCs and ECs, which may be involved in the excessive acceleration of atherosclerosis in patients with diabetes and insulin resistance syndrome.
Journal ArticleDOI

Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat.

TL;DR: It is shown that Dgat-deficient (Dgat−/−) mice are viable and can still synthesize triglycerides, and these mice are lean and resistant to diet-induced obesity.
Related Papers (5)